Pyridine-4-carboxilic acid hydrazide, commercially known as isoniazid (INH), is an antitubercular drug and is now widely used together with rifampicin and streptomycin for the chemotherapy of tuberculosis. This has prompted many researchers to develop accurate and rapid methods for the determination of INH in pure and pharmaceutical formulations. Of the various techniques used for the determination of this drug, FIA-spectrofluorometry, 1,2 polarography 3 and adsorptive stripping voltammetry 4 are of high cost and are not available at most quality-control laboratories. Other methods include highperformance liquid chromatography 5 and indirect potentiometric titration.
Pyridine-4-carboxilic acid hydrazide, commercially known as isoniazid (INH) , is an antitubercular drug and is now widely used together with rifampicin and streptomycin for the chemotherapy of tuberculosis. This has prompted many researchers to develop accurate and rapid methods for the determination of INH in pure and pharmaceutical formulations. Of the various techniques used for the determination of this drug, FIA-spectrofluorometry, 1,2 polarography 3 and adsorptive stripping voltammetry 4 are of high cost and are not available at most quality-control laboratories. Other methods include highperformance liquid chromatography 5 and indirect potentiometric titration. 6 Many spectrophotometric methods have been described for the assay of INH in pharmaceutical preparations; some of these are either time bound, 7-9 involve extraction, 10 require heating, 11, 12 need cooling to lower the temperature for a long time 13 or are less sensitive. 11, 14 The United States Pharmacopoeia (USP) method 15 involves a titration procedure, which is both laborious and time consuming. Hence, it was planned to develop a reasonably sensitive and economically viable technique, like a spectrophotometric procedure.
In the present paper, we report on a rapid and sensitive spectrophotometric method for the determination of INH in pure and pharmaceutical formulations based on the oxidation of 4,5-dihydroxy-1,3-benzenedisulfonic acid (Tiron) by sodium metaperiodate (SPI) followed by oxidative coupling with INH in an alkaline medium.
Experimental

Apparatus
A Hitachi UV-visible spectrophotometer Model U-2001 with 1-cm matched quartz cells was used for all absorbance measurements.
Reagents and samples
All of the chemicals used were of either pharmaceutical or analytical grade. Quartz-processed high-purity distilled water was used throughout. A standard solution of INH was prepared by dissolving a requisite amount of INH in distilled water. It was diluted as and when required. A 0.5% solution of each of SPI and tiron and a 0.1 M NaOH solution were prepared separately in distilled water.
Determination of pure drug
Aliquots of standard solutions of INH were transferred into a series of 10 ml calibrated flasks. To each of these were added 0.25 ml of SPI, 0.5 ml tiron and 1.25 ml of NaOH and diluted to the mark with distilled water. The absorbances of the redcolored product were determined at 507 nm against a reagent blank. Calibration graph was constructed or the regression equation calculated.
Analysis of pharmaceutical formulations
Twenty tablets of INH were weighed, finely powdered and an amount equivalent to 50 mg of INH was dissolved in water and filtered. The filtrate was made up to 100 ml and a suitable amount of an aliquot was treated as described above for a pure sample.
For the syrup, an appropriate volume of the sample was taken and analyzed for INH using the procedure described for a pure sample.
Results and Discussion
Tiron readily undergoes oxidation by SPI, which further couples with INH in the presence of sodium hydroxide to form an intense red-colored product having an absorption maximum at 507 nm, as shown in Fig. 1 . The reagent blank does not absorb around this wavelength. The tentative reaction mechanism for the formation of an oxidative coupled product 14 may be represented as shown in Fig. 2 . Other oxidizing agents viz., quinolinium dichromate, chloramine T, sodium orthovanadate, pyridinium chlorochromate, iodic acid and potassium bromate, did not give the red-colored product when tried in place of SPI. Less-intense red-colored products were obtained with Nbromosuccinimide, K3[Fe(CN)6], Ce(IV), BrCl, ICl3 and K2Cr2O7. The oxidative coupled product was stable in the 10 -40˚C temperature range. The absorbance values remained constant for 40 min at room temperature (27˚C). At higher temperatures, the absorbance values decreased, indicating dissociation of the product. The effects of the reagents viz., SPI, tiron and NaOH were studied by measuring the absorbances of solutions containing a fixed concentration of INH and varying amounts of reagents at 507 nm. The constant and maximum absorbance readings were obtained with 0.25 ml of 0.5% SPI,
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0.5 ml of 0.5% Tiron and 1.25 ml of 0.1 M NaOH. The order of the addition of reagents was critical for the color development, and NaOH should be added at the end, as stated in the procedure.
Analytical features
The method obeyed Beer's law in the concentration range of 1 -15 µg/ml with molar absorptivity and Sandell's sensitivity values of 1.84 × 10 4 l mol -1 cm -1 and 18.05 ng cm -2 , respectively. A regression analysis of a Beer's law plot at 507 nm revealed a good correlation (r = 0.9995). The graph of the absorbance versus the concentration of INH showed a low intercept (-0.0820) and slope (0.0645), and is described by a regression equation, Y = aX + b (where X is the concentration of INH in µg/ml, Y is the absorbance of a 1 cm layer, a is the slope and b is the intercept). The low relative standard deviation (0.82%) and the range of error at the 95% confidence level (0.67) for the analysis of five replicates of 10 µg/ml indicated good precision and the accuracy of the proposed method.
Interference studies
In order to assess the possible analytical applications of the proposed method, the effects of some substances that often accompany INH in various pharmaceutical products were studied by adding different amounts of substances to 10 µg ml -1 of INH. An attractive feature of the method is its relative freedom from interference by the usual tablet diluents and excipients in amounts far in excess of their normal occurrence in pharmaceutical preparations. The results are given in Table 1 .
Application of the method
The applicability of the proposed method was examined as an assay of pharmaceutical preparations. The results of the assay of INH tablets and syrups (Table 2 ) compare favorably with the quoted values and those obtained by an official 14 method.
Statistical analysis of the results in comparison with the official method
The performance of the proposed method was judged by calculating the Student t-test and variance ratio F-test. At the 95% confidence level, the calculated t-and F-values do not exceed the theoretical values ( Table 2 ), indicating that there is no significant difference between the proposed method and the official 14 method.
From an analytical point of view, it is concluded that the described procedure allows for the determination of INH in pure and pharmaceutical dosage forms.
Unlike the spectrofluorometer, as well as gas chromatographic and HPLC procedures, the instrument is simple and inexpensive. Its importance lies in the chemical reaction upon which the procedure is based, rather than upon the sophistication of the instrument. This aspect of spectrophotometric analysis is of major interest in analytical pharmacy, since it offers a distinct possibility in the assay of a particular component in complex dosage formulations. The reagents utilized in the proposed methods are cheaper and readily available, and the procedure does not involve any critical reaction conditions, such as heating, extraction or tedious sample preparation, and hence could be used for routine quality control.
